RxDoctor Payments Data

Paula Mendes

Neurology · Boulder, CONPI 1821082819

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $38,606 of the $42,058 with a category attached, or 91.8%. Amgen accounts for 95.2% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2019 at $28,019 and has fallen 86.7% since, to $3,716 in 2022.

$42,058in general payments, 2019–2025

Across 139 payments — averaging $302.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$40K
  • Novartis$371
  • Biogen$334
  • EMD Serono, Inc.$207
  • Biohaven Pharmaceutical Holding Company Ltd.$194
  • AbbVie$142
  • plus $790 from 18 others

What the payments were for

  • Consulting fees$1500%
  • Speaking & faculty fees$38,60692%
  • Travel & lodging$4371%
  • Food & beverage$2,8447%
  • Education$210%

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$42,058 in reported general payments places this provider in the 85th percentile of 334 neurology providers in Colorado.

See all neurology providers in Colorado →

Other neurology in Boulder

See the full list for Colorado →

Where these figures come from

Is this you, or does something look wrong? →